5-Fluorouracil |
5-FU |
Antimetabolite (DNA & RNA) |
Other |
3385 |
GDSC1 |
907 |
MGH |
5-Fluorouracil |
5-FU |
Antimetabolite (DNA & RNA) |
Other |
3385 |
GDSC2 |
968 |
SANGER |
5-azacytidine |
|
DNA methyltransferases |
Other |
|
GDSC2 |
740 |
SANGER |
AZD6094 |
SN1042487586 |
MET |
RTK signaling |
|
GDSC1 |
919 |
SANGER |
Ara-G |
9-??-D-Arabinofuranosyl guanine |
Anti-metabolite |
Other |
|
GDSC1 |
906 |
MGH |
BDILV000379a |
4-(4-(1-methyl-1H-pyrazol-4-yl)-1-(2-(1-methyl-1H-pyrazol-4-yl)ethyl)-4,5-dihydro-1H-imidazol-5-yl)benzonitrile |
BAZ2A, BAZ2B |
Chromatin histone acetylation |
|
GDSC2 |
717 |
SANGER |
BDOCA000347a |
4-bromo-N-(6-methoxy-1,3-dimethyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)-2-methylbenzenesulfonamide |
BRPF1, BRPF2, BRPF3 |
Chromatin histone acetylation |
|
GDSC2 |
717 |
SANGER |
Bromosporine |
ethyl N-[6-(3-methanesulfonamido-4-methylphenyl)-3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-8-yl]carbamate |
CECR2, BRD2, BRD4, BRD9 |
Chromatin other |
|
GDSC2 |
716 |
SANGER |
CPI-613 |
|
Metabo, Mitochondria |
Other |
|
GDSC1 |
909 |
MGH |
Cabozantinib |
BMS-907351, XL-184, Cometriq |
VEGFR, MET, RET, KIT, FLT1, FLT3, FLT4, TIE2,AXL |
RTK signaling |
25102847 |
GDSC1 |
911 |
MGH |
Crizotinib |
Xalkori, PF2341066, PF-2341066, PF 2341066 |
MET, ALK, ROS1 |
RTK signaling |
11626560 |
GDSC1 |
405 |
MGH |
Crizotinib |
Xalkori, PF2341066, PF-2341066, PF 2341066 |
MET, ALK, ROS1 |
RTK signaling |
11626560 |
GDSC2 |
966 |
SANGER |
Cytarabine |
Ara-Cytidine, Arabinosyl Cytosine, U-19920 |
Antimetabolite |
Other |
6253 |
GDSC1 |
923 |
SANGER |
Cytarabine |
Ara-Cytidine, Arabinosyl Cytosine, U-19920 |
Antimetabolite |
Other |
6253 |
GDSC2 |
743 |
SANGER |
DMOG |
Dimethyloxalylglcine |
HIF-PH |
Metabolism |
560326 |
GDSC1 |
876 |
MGH |
EPZ5676 |
EPZ-5676, Pinometostat |
DOT1L |
Chromatin histone methylation |
57345410 |
GDSC2 |
962 |
SANGER |
FY026 |
[(para-cymene)osmium(N,N-dimethylphenlyazopyridine)(iodide)]hexafluorophophate |
|
Unclassified |
|
GDSC1 |
915 |
SANGER |
Fludarabine |
Fludara |
Antimetabolite |
DNA replication |
|
GDSC2 |
717 |
SANGER |
Foretinib |
GSK1363089, XL-880, EXEL-2880, GSK089 |
MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR |
RTK signaling |
42642645 |
GDSC1 |
909 |
MGH |
Foretinib |
GSK1363089, XL-880, EXEL-2880, GSK089 |
MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR |
RTK signaling |
42642645 |
GDSC2 |
953 |
SANGER |
GSK2801 |
1-(7-(2-methylsulfonyl-phenyl)-4-propoxy-1-aza-bicyclo[4.3.0]nona-2,4,6,8-tetraen-9-yl)-ethanone |
|
Chromatin other |
|
GDSC2 |
717 |
SANGER |
Gemcitabine |
Gemzar, LY-188011 |
Pyrimidine antimetabolite |
DNA replication |
60750 |
GDSC1 |
859 |
MGH |
Gemcitabine |
|
Pyrimidine antimetabolite |
DNA replication |
|
GDSC1 |
920 |
SANGER |
Gemcitabine |
Gemzar, LY-188011 |
Pyrimidine antimetabolite |
DNA replication |
60750 |
GDSC2 |
960 |
SANGER |
JNJ38877605 |
|
MET |
RTK signaling |
|
GDSC1 |
917 |
MGH |
MetAP2 Inhibitor, A832234 |
|
MetAP2 |
Other |
|
GDSC1 |
903 |
MGH |
Methotrexate |
Abitrexate, Amethopterin, Rheumatrex, Trexall, Folex |
Antimetabolite |
DNA replication |
126941 |
GDSC1 |
933 |
SANGER |
Methotrexate |
Abitrexate, Amethopterin, Rheumatrex, Trexall, Folex |
Antimetabolite |
DNA replication |
126941 |
GDSC2 |
881 |
SANGER |
N-acetyl cysteine |
NAC |
Metabolism |
Metabolism |
None |
GDSC2 |
735 |
SANGER |
N23918-95-7 |
|
JMJ histone demethylase |
Chromatin histone methylation |
|
GDSC1 |
913 |
SANGER |
N24798-49-A1 |
|
JMJ histone demethylase |
Chromatin histone methylation |
|
GDSC1 |
908 |
SANGER |
PHA-665752 |
PHA665752, PHA 665752 |
MET |
RTK signaling |
10461815 |
GDSC1 |
405 |
MGH |
PRIMA-1MET |
Prima 1MET, APR-246 |
TP53 activation |
p53 pathway |
52918385 |
GDSC2 |
894 |
SANGER |
Pemetrexed |
|
TYMS |
DNA replication |
|
GDSC1 |
899 |
MGH |
Pyrimethamine |
Daraprim, Chloridine |
Dihydrofolate reductase (DHFR) |
Other |
4993 |
GDSC1 |
398 |
MGH |
Refametinib |
RDEA119, BAY-86-9766, BAY 869766 |
MEK1, MEK2 |
ERK MAPK signaling |
44182295 |
GDSC1 |
913 |
SANGER |
Refametinib |
RDEA119, BAY-86-9766, BAY 869766 |
MEK1, MEK2 |
ERK MAPK signaling |
44182295 |
GDSC1 |
861 |
SANGER |
Refametinib |
RDEA119, BAY-86-9766, BAY 869766 |
MEK1, MEK2 |
ERK MAPK signaling |
44182295 |
GDSC2 |
947 |
SANGER |
SGC-CBP30 |
8-(3-chloro-4-methoxy-phenethyl)-4-(3,5-dimethyl-isoxazol-4-yl)-9-(2-(morpholin-4-yl)-propyl)-7,9-diaza-bicyclo[4.3.0]nona-1(6),2,4,7-tetraene |
EP300, CBP |
Chromatin histone acetylation |
|
GDSC2 |
716 |
SANGER |
SU11274 |
|
MET |
RTK signaling |
|
GDSC1 |
918 |
MGH |
Savolitinib |
AZD6094, Volitinib, AZD-6094, AZD 6094 |
MET |
RTK signaling |
68289010 |
GDSC2 |
957 |
SANGER |
Selumetinib |
AZD6244, AZD-6244, ARRY-886 |
MEK1, MEK2 |
ERK MAPK signaling |
10127622 |
GDSC1 |
880 |
SANGER |
Selumetinib |
AZD6244, AZD-6244, ARRY-886 |
MEK1, MEK2 |
ERK MAPK signaling |
10127622 |
GDSC1 |
906 |
SANGER |
Selumetinib |
AZD6244, AZD-6244, ARRY-886 |
MEK1, MEK2 |
ERK MAPK signaling |
10127622 |
GDSC2 |
949 |
SANGER |
Selumetinib |
SN1103949345, AZD1480 |
MEK1, MEK2 |
ERK MAPK signaling |
|
GDSC2 |
717 |
SANGER |
Serdemetan |
JNJ-26854165 |
MDM2 |
p53 pathway |
11609586 |
GDSC1 |
924 |
SANGER |
Serdemetan |
JNJ-26854165 |
MDM2 |
p53 pathway |
11609586 |
GDSC2 |
948 |
SANGER |
Trametinib |
GSK1120212, Mekinist |
MEK1, MEK2 |
ERK MAPK signaling |
11707110 |
GDSC1 |
881 |
SANGER |
Trametinib |
GSK1120212, Mekinist |
MEK1, MEK2 |
ERK MAPK signaling |
11707110 |
GDSC2 |
966 |
SANGER |
UNC0638 |
UNC-0638, UNC 0683 |
G9a and GLP methyltransferases |
Chromatin histone methylation |
46224516 |
GDSC1 |
907 |
MGH |
UNC0638 |
UNC-0638, UNC 0683 |
G9a and GLP methyltransferases |
Chromatin histone methylation |
46224516 |
GDSC1 |
914 |
SANGER |
ZL049 |
[(diphenyltetramethylcyclopentadienyl)iridium(III)(2-phenylpyridine)(chloride)] |
|
Unclassified |
|
GDSC1 |
913 |
SANGER |
Zoledronate |
Zoledronic acid, Zometa, Reclast |
|
Other |
|
GDSC2 |
717 |
SANGER |
alpha-lipoic acid |
aLA |
Metabolism |
Metabolism |
None |
GDSC2 |
735 |
SANGER |